Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2023-08-30
- Target Recruit Count
- 544
- Registration Number
- NCT03127761
- Locations
- 🇺🇸
Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, United States
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2023-08-30
- Target Recruit Count
- 650
- Registration Number
- NCT02934477
- Locations
- 🇺🇸
Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, United States
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
- Conditions
- Interventions
- Drug: FludarabineDrug: Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5Drug: Cyclophosphamide 50mg/kg/day IV on Days -5,-4Radiation: Total Body Irradiation (TBI) 200cGy on Day -1Drug: Cyclophosphamide 50mg/kg/day IV on Days -2,-1Drug: BusulfanRadiation: Total Body Irradiation (TBI) 200cGy twice a day on Days -3, -2, -1Procedure: Infusion of non-T-cell depleted bone marrow on Day 0Drug: Post-HCT Cyclophosphamide 50mg/kg IV on Day+3, +4Drug: SirolimusDrug: Mycophenolate mofetilDrug: G-CSFDrug: Pre-HCT Mesna on Days -2 and -1Drug: Pre-HCT Mesna on Days -5 and -4Drug: Pre-HCT Mesna on Days -6 and -5Drug: Post-HCT Mesna
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2020-12-02
- Target Recruit Count
- 80
- Registration Number
- NCT02793544
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center - Adults, New York, New York, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program, Richmond, Virginia, United States
Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation
- Conditions
- Interventions
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2015-09-16
- Target Recruit Count
- 1
- Registration Number
- NCT02338050
- Locations
- 🇺🇸
Childrens Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2023-02-08
- Target Recruit Count
- 340
- Registration Number
- NCT02338479
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸Dana Farber Cancer Institute - Pediatrics, Boston, Massachusetts, United States
Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors
- Conditions
- Interventions
- First Posted Date
- 2014-07-25
- Last Posted Date
- 2017-09-07
- Target Recruit Count
- 495
- Registration Number
- NCT02200133
- Locations
- 🇺🇸
University of Kansas Cancer Center, Westwood, Kansas, United States
🇺🇸University Hospitals Case Medical Center, Cleveland, Ohio, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT
- Conditions
- Interventions
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2016-10-12
- Target Recruit Count
- 40
- Registration Number
- NCT01772953
- Locations
- 🇺🇸
Washington University, St. Louis Children's, St. Louis, Missouri, United States
🇺🇸Children's National Medical Center, Washington, DC, District of Columbia, United States
🇺🇸Children's Hospital of Alabama/UAB, Birmingham, Alabama, United States
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
- Conditions
- Interventions
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2023-09-14
- Target Recruit Count
- 127
- Registration Number
- NCT01696461
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia
- Conditions
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2017-09-07
- Target Recruit Count
- 150
- Registration Number
- NCT01385787
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸The Children's Hospital of Alabama, University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Loma Linda University, Loma Linda, California, United States
National Marrow Donor Program Long-Term Donor Follow-Up
- Conditions
- First Posted Date
- 2011-05-30
- Last Posted Date
- 2020-10-20
- Target Recruit Count
- 21974
- Registration Number
- NCT01362179
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸National Marrow Donor Program Northeast District, Philadelphia, Pennsylvania, United States
🇺🇸Baylor Research Institute, Dallas, Texas, United States